290 related articles for article (PubMed ID: 33173344)
1. Effect of Immune Checkpoint Inhibitors Plus Chemotherapy on Advanced Gastric Cancer Patients with Elevated Serum AFP or Hepatoid Adenocarcinoma.
Li W; Li Q; Yu Y; Wang Y; Chen E; Chen L; Wang Z; Cui Y; Liu T
Cancer Manag Res; 2020; 12():11113-11119. PubMed ID: 33173344
[TBL] [Abstract][Full Text] [Related]
2. Treatment efficacy of ramucirumab-containing chemotherapy in patients with alpha-fetoprotein producing gastric cancer.
Kamiimabeppu D; Wakatsuki T; Takahari D; Fukuda N; Shimozaki K; Osumi H; Nakayama I; Ogura M; Ooki A; Shinozaki E; Chin K; Yamaguchi K
Int J Clin Oncol; 2023 Jan; 28(1):121-129. PubMed ID: 36409433
[TBL] [Abstract][Full Text] [Related]
3. Combinational zimberelimab plus lenvatinib and chemotherapy for alpha-fetoprotein elevated, advanced gastric cancer patients (AFPGC): a phase 1 dose-escalation study.
Deng T; Wang F; Zhang L; Ning T; Sun Y; Ge S; Bai M; Lu Y; Li H; Ba Y
Cancer Immunol Immunother; 2024 Jun; 73(8):154. PubMed ID: 38833154
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of apatinib for the treatment of AFP-producing gastric cancer.
Li N; Bai C; Zhang R; Ma L; Ren X; Zhang J; Fu Z; Zhao L
Transl Oncol; 2021 Feb; 14(2):101004. PubMed ID: 33383486
[TBL] [Abstract][Full Text] [Related]
5. The clinicopathological features and prognosis of serum AFP positive gastric cancer: a report of 16 cases.
Liu D; Li B; Yan B; Liu L; Jia Y; Wang Y; Ma X; Yang F
Int J Clin Exp Pathol; 2020; 13(9):2439-2446. PubMed ID: 33042357
[TBL] [Abstract][Full Text] [Related]
6. Hepatoid Adenocarcinoma of Stomach: Emphasis on the Clinical Relationship with Alpha-Fetoprotein-Positive Gastric Cancer.
Chen EB; Wei YC; Liu HN; Tang C; Liu ML; Peng K; Liu T
Biomed Res Int; 2019; 2019():6710428. PubMed ID: 31915699
[TBL] [Abstract][Full Text] [Related]
7. Decreased expression of claudin-18.2 in alpha-fetoprotein-producing gastric cancer compared to conventional gastric cancer.
Weng W; Zhang M; Ni S; Tan C; Xu M; Wang X; Sun H; Wang L; Huang D; Sheng W
J Gastrointest Oncol; 2022 Jun; 13(3):1035-1045. PubMed ID: 35837176
[TBL] [Abstract][Full Text] [Related]
8. Effect of immune checkpoint inhibitors in patients with gastric hepatoid adenocarcinoma: a case report and literature review.
Sun Y; Chang W; Yao J; Liu H; Zhang X; Wang W; Zhao K
J Int Med Res; 2022 Apr; 50(4):3000605221091095. PubMed ID: 35469480
[TBL] [Abstract][Full Text] [Related]
9. Apatinib in Combination with S-1 as First-Line Treatment in Patients with Advanced Metastatic Gastric Cancer: Results from an Open, Exploratory, Single-Arm, Phase II Trial.
Zhou N; Zhang C; Liu D; Liu K; Wang G; Zhu H; Zhang J; Jiang M; Liu N; Zhang X
Oncologist; 2021 Mar; 26(3):e374-e381. PubMed ID: 33244809
[TBL] [Abstract][Full Text] [Related]
10. Re-evaluation of the prognosis of alpha-fetoprotein-producing gastric cancer from a single center: a case series study.
Akabane M; Yago A; Haruta S; Ohkura Y; Ueno M; Udagawa H
Langenbecks Arch Surg; 2023 Jan; 408(1):66. PubMed ID: 36695913
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological and molecular characteristics of the alpha-fetoprotein-producing gastric cancer: emphasis on two major subtypes.
Lu J; Jin M; Zhou X; Chen X; Shao Y; Jiang X
APMIS; 2022 Mar; 130(3):169-180. PubMed ID: 34862662
[TBL] [Abstract][Full Text] [Related]
12. An analysis of clinical characteristics and prognosis for patients with serum alpha-fetoprotein-positive gastric cancer.
Zuo CT; Ju Q
Minerva Med; 2015 Aug; 106(4):185-91. PubMed ID: 26418320
[TBL] [Abstract][Full Text] [Related]
13. Pathologic complete response of hepatoid adenocarcinoma of the stomach after chemo-immunotherapy: A rare case report and literature review.
Zhou Y; Dong L; Dai L; Hu S; Sun Y; Wu Y; Pan T; Li X
Front Surg; 2023; 10():1133335. PubMed ID: 37065996
[TBL] [Abstract][Full Text] [Related]
14. [AFP-producing gastric cancer and hepatoid gastric cancer].
Wang YK; Zhang XT
Zhonghua Zhong Liu Za Zhi; 2017 Nov; 39(11):801-807. PubMed ID: 29151285
[TBL] [Abstract][Full Text] [Related]
15. Large Scale, Multicenter, Prospective Study of Apatinib in Advanced Gastric Cancer: A Real-World Study from China.
Peng W; Zhang F; Wang Z; Li D; He Y; Ning Z; Sheng L; Wang J; Xia X; Yu C; Wang Z; Zhao Y; Liang H; Hu B; Sun C; Wang D; Cheng Y; Pan M; Xia L; Guo X; Zhang Y; Hu Z; Li X; Lu L; Zhang J; Qian H; Xie H; Sun G
Cancer Manag Res; 2020; 12():6977-6985. PubMed ID: 32821164
[TBL] [Abstract][Full Text] [Related]
16. The Relationship Between D-dimer and Prognosis in the Patients with Serum Alpha-Fetoprotein-Positive Gastric Cancer: A Retrospective Cohort Study.
Zhang X; Wang W; Tian B; Wang Y; Jing J
Clin Med Insights Oncol; 2022; 16():11795549221120158. PubMed ID: 36104997
[TBL] [Abstract][Full Text] [Related]
17. Significant response to ramucirumab monotherapy in chemotherapy-resistant recurrent alpha-fetoprotein-producing gastric cancer: A case report.
Arakawa Y; Tamura M; Aiba K; Morikawa K; Aizawa D; Ikegami M; Yuda M; Nishikawa K
Oncol Lett; 2017 Sep; 14(3):3039-3042. PubMed ID: 28928842
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics and treatments of patients with alpha-fetoprotein producing gastric carcinoma.
Gong W; Su Y; Liu A; Liu J; Sun D; Jiang T; Xiang J; Chi C; Sun P
Neoplasma; 2018 Mar; 65(3):326-330. PubMed ID: 29788728
[TBL] [Abstract][Full Text] [Related]
19. Complete remission of alpha-fetoprotein-producing gastric cancer by combined tislelizumab-apatinib treatment of a patient with proficient mismatch repair: a case report.
Xiang J; Gong W; Wang C; Sun P; Liu A
World J Surg Oncol; 2022 Sep; 20(1):289. PubMed ID: 36076263
[TBL] [Abstract][Full Text] [Related]
20. [Clinicopathologic characteristics and prognosis of gastric hepatoid adenocarcinoma].
Zhao R; Wang X; Lan X; Li M
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1035-1039. PubMed ID: 28900996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]